Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort.
Cervo A, Russo A, Di Carlo D, De Vito A, Fabeni L, D'Anna S, Duca L, Colpani A, Fois M, Zauli B, Mancarella G, Carraro A, Bezenchek A, Cozzi-Lepri A, Santoro MM; ARCA Study Group. Cervo A, et al. Among authors: bezenchek a. J Glob Antimicrob Resist. 2023 Sep;34:141-144. doi: 10.1016/j.jgar.2023.07.006. Epub 2023 Jul 13. J Glob Antimicrob Resist. 2023. PMID: 37453495 Free article.
Trend over time of HIV-1 drug resistance to nonnucleoside reverse transcriptase inhibitors (NNRTIs) and their drivers: A cohort study from Antiviral Response Cohort Analysis (ARCA).
Rancan I, Cassol C, Graziani L, Tilli M, Malcontenti C, Russo C, Bottanelli M, Bracchitta F, Papaioannu R, Labate L, Mora S, Bezenchek A, Shallvari A, Di Biagio A, Rossetti B. Rancan I, et al. Among authors: bezenchek a. HIV Med. 2023 Nov;24(11):1150-1157. doi: 10.1111/hiv.13525. Epub 2023 Jul 13. HIV Med. 2023. PMID: 37439411
Impact of pre-existent drug resistance on virological efficacy of single-tablet regimens in people living with HIV.
Stella G, Volpicelli L, Carlo DD, Vicenti I, Celani L, Maggiolo F, Callegaro AP, Gennari W, Francisci D, Lombardi F, Piermatteo L, Bezenchek A, Micheli V, Rossetti B, Santoro MM; ARCA Study Group. Stella G, et al. Among authors: bezenchek a. Int J Antimicrob Agents. 2022 Sep;60(3):106636. doi: 10.1016/j.ijantimicag.2022.106636. Epub 2022 Jul 9. Int J Antimicrob Agents. 2022. PMID: 35820534
Early versus delayed antiretroviral therapy based on genotypic resistance test: Results from a large retrospective cohort study.
Bavaro DF, De Vito A, Pasculli G, Bouba Y, Magnasco L, Pincino R, Saladini F, Lattanzio R, Corsini R, Arima S, Zazzi M, Incardona F, Rossetti B, Bezenchek A, Vanni B, Di Biagio A. Bavaro DF, et al. Among authors: bezenchek a. J Med Virol. 2022 Aug;94(8):3890-3899. doi: 10.1002/jmv.27754. Epub 2022 Apr 9. J Med Virol. 2022. PMID: 35355293 Free PMC article.
Predictors of Virological Failure Among People Living with HIV Switching from an Effective First-Line Antiretroviral Regimen.
Magnasco L, Pincino R, Pasculli G, Bouba Y, Saladini F, Bavaro DF, De Vito A, Lattanzio R, Corsini R, Zazzi M, Incardona F, Rossetti B, Bezenchek A, Borghi V, Di Biagio A. Magnasco L, et al. Among authors: bezenchek a. AIDS Res Hum Retroviruses. 2022 Jun;38(6):463-471. doi: 10.1089/AID.2021.0016. Epub 2022 Feb 10. AIDS Res Hum Retroviruses. 2022. PMID: 34969260
Prevalence and factors associated with HIV-1 multi-drug resistance over the past two decades in the Italian ARCA database.
Lombardi F, Giacomelli A, Armenia D, Lai A, Dusina A, Bezenchek A, Timelli L, Saladini F, Vichi F, Corsi P, Colao G, Bruzzone B, Gagliardini R, Callegaro A, Castagna A, Santoro MM; ARCA Study Group. Lombardi F, et al. Among authors: bezenchek a. Int J Antimicrob Agents. 2021 Feb;57(2):106252. doi: 10.1016/j.ijantimicag.2020.106252. Epub 2020 Nov 28. Int J Antimicrob Agents. 2021. PMID: 33259914 Free article.
Supporting Iraqi Kurdistan Health Authorities in Post-conflict Recovery: The Development of a Health Monitoring System.
Emberti Gialloreti L, Basa FB, Moramarco S, Salih AO, Alsilefanee HH, Qadir SA, Bezenchek A, Incardona F, Di Giovanni D, Khorany R, Alhanabadi LHH, Salih SO, Akhshirsh GS, Azeez BS, Tofiq BA, Palombi L. Emberti Gialloreti L, et al. Among authors: bezenchek a. Front Public Health. 2020 Jan 30;8:7. doi: 10.3389/fpubh.2020.00007. eCollection 2020. Front Public Health. 2020. PMID: 32083050 Free PMC article.
Impact of NRTI resistance mutations on virological effectiveness of antiretroviral regimens containing elvitegravir: a multi-cohort study.
Modica S, Redi D, Gagliardini R, Giombini E, Bezenchek A, Di Carlo D, Maggiolo F, Lombardi F, Borghetti A, Farinacci D, Callegaro A, Gismondo MR, Colafigli M, Sterrantino G, Costantini A, Ferrara SM, Rusconi S, Zazzi M, Rossetti B, De Luca A, Gianotti N. Modica S, et al. Among authors: bezenchek a. J Antimicrob Chemother. 2020 Jan 1;75(1):194-199. doi: 10.1093/jac/dkz424. J Antimicrob Chemother. 2020. PMID: 31605107
13 results